Neuroscience of attention-deficit/hyperactivity disorder: The search for endophenotypes

Nature Reviews Neuroscience

Volumn 3, Issue 8, 2002, Pages 617-628

  Castellanos, F Xavier ^a   Tannock, Rosemary ^b  

^a NEW YORK UNIVERSITY   (United States)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE;

ANIMAL; ATTENTION DEFICIT DISORDER; BRAIN; BRAIN LEVEL; CHILD; FEMALE; GENETICS; HUMAN; HYPERKINESIA; METABOLISM; NERVE CELL INHIBITION; NERVE TRACT; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; POINT MUTATION; PREGNANCY; PRENATAL EXPOSURE; REVIEW;

ANIMALS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BRAIN; BRAIN CHEMISTRY; CHILD; DOPAMINE; FEMALE; HUMANS; HYPERKINESIS; NEURAL INHIBITION; NEURAL PATHWAYS; PHENOTYPE; POINT MUTATION; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 0036674495     PISSN: 14710048     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrn896     Document Type: Review

References (145)

1. Goldman, L. S., Genel, M., Bezman, R. J. & Slanetz, P. J. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association. JAMA 279, 1100-1107 (1998).
2. Barbaresi, W. J. et al. How common is attention-deficit/ hyperactivity disorder? Incidence in a population-based birth cohort in Rochester, Minn. Arch. Pediatr. Adolesc. Med. 156, 217-224 (2002).
3. LeFever, G. B., Dawson, K. V. & Morrow, A. L. The extent of drug therapy for attention deficit-hyperactivity disorder among children in public schools. Am. J. Public Health 89, 1359-1364 (1999).
4. Moll, G. H., Hause, S., Ruther, E., Rothenberger, A. & Huether, G. Early methylphenidate administration to young rats causes a persistent reduction in the density of striatal dopamine transporters. J. Child Adolesc. Psychopharmacol. 11, 15-24 (2001).
5. Zito, J. M. et al. Trends in the prescribing of psychotropic medications to preschoolers. JAMA 283, 1025-1030 (2000).
6. Morton, J. & Frith, U. in Developmental Psychopathology (eds Cicchetti, D. & Cohen, D. J.) 357-390 (John Wiley, New York, 1995).
7. Almasy, L. & Blangero, J. Endophenotypes as quantitative risk factors for psychiatric disease: rationale and study design. Am. J. Med. Genet. 105, 42-44 (2001).
8. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (American Psychiatric Association, Washington DC, 1994).
9. Swanson, J. M. et al. Seminar: attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet 351, 429-433 (1998).
10. Landgren, M., Kjellman, B. & Gillberg, C. Deficits in attention, motor control and perception (DAMP): a simplified school entry examination. Acta Paediatr. 89, 302-309 (2000).
11. Sonuga-Barke, E. J. Psychological heterogeneity in AD/HD - a dual pathway model of behaviour and cognition. Behav. Brain Res. 130, 29-36 (2002).
12. Barkley, R. A. Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol. Bull. 121, 65-94 (1997).
13. Sergeant, J., Oosterlaan, J. & Van der Meere, J. in Handbook of Disruptive Behavior Disorders (eds Quay, H. C. & Hogan, A. E.) 75-104 (Plenum, New York, 1999).
14. Nigg, J. T. Is ADHD a disinhibitory disorder? Psychol. Bull. 127, 571-598 (2001).
15. Solanto, M. V. Arnsten, A. F. T. & Castellanos, F. X. (eds) Stimulant Drugs and ADHD: Basic and Clinical Neuroscience (Oxford Univ. Press, New York, 2001).
16. Rutter, M. & Silberg, J. Gene-environment interplay in relation to emotional and behavioral disturbance. Annu. Rev. Psychol. 53, 463-490 (2002).
17. Smalley, S. L. Genetic influences in childhood-onset psychiatric disorders: autism and attention-deficit/hyperactivity disorder. Am. J. Hum. Genet. 60, 1276-1282 (1997).
18. Tannock, R. Attention deficit hyperactivity disorder: advances in cognitive, neurobiological, and genetic research. J. Child Psychol. Psychiatry 39, 65-99 (1998).
19. Faraone, S. V. & Doyle, A. E. Genetic influences on attention deficit hyperactivity disorder. Curr. Psychiatry Rep. 2, 143-146 (2000).
20. Swanson, J. M. et al. Dopamine genes and ADHD. Neurosci. Biobehav. Rev. 24, 21-25 (2000).
21. Faraone, S. V. Report from the third international meeting of the Attention-Deficit Hyperactivity Disorder Molecular Genetics Network. Am. J. Med. Genet. 114, 272-276 (2002).
22. Fisher, S. E. et al. A genomewide scan for loci involved in attention-deficit/hyperactivity disorder. Am. J. Hum. Genet. 70, 1183-1196 (2002).
23. International Molecular Genetic Study of Autism Consortium (IMGSAC). A genomewide screen for autism: strong evidence for linkage to chromosomes 2q, 7q, and 16p. Am. J. Hum. Genet. 69, 570-581 (2001).
24. Herskovits, E. H. et al. Is the spatial distribution of brain lesions associated with closed-head injury predictive of subsequent development of attention-deficit/hyperactivity disorder? Analysis with brain-image database. Radiology 213, 389-394 (1999).
25. Max, J. E. et al. Putamen lesions and the development of attention-deficit/hyperactivity symptomatology. J. Am. Acad. Child Adolesc. Psychiatry 41, 563-571 (2002).
26. Kreppner, J. M., O'Connor, T. G. & Rutter, M. Can inattention/overactivity be an institutional deprivation syndrome? J. Abnorm. Child Psychol. 29, 513-528 (2001).
27. Biederman, J. et al. Family-environment risk factors for attention-deficit hyperactivity disorder. A test of Rutter's indicators of adversity. Arch. Gen. Psychiatry 52, 464-470 (1995).
28. Mick, E., Biederman, J., Faraone, S. V., Sayer, J. & Kleinman, S. Case-control study of attention-deficit hyperactivity disorder and maternal smoking, alcohol use, and drug use during pregnancy. J. Am. Acad. Child Adolesc. Psychiatry 41, 378-385 (2002).
29. Hellstrom-Lindahl, E., Gorbounova, O., Seiger, A., Mousavi, M. & Nordberg, A. Regional distribution of nicotinic receptors during prenatal development of human brain and spinal cord. Brain Res. Dev. Brain Res. 108, 147-160 (1998).
30. Roy, T. S., Seidler, F. J. & Slotkin, T. A. Prenatal nicotine exposure evokes alterations of cell structure in hippocampus and somatosensory cortex. J. Pharmacol. Exp. Ther. 300, 124-133 (2002).
31. Lim, D. K. & Kim, H. S. Changes in the glutamate release and uptake of cerebellar cells in perinatally nicotine-exposed rat pups. Neurochem. Res. 26, 1119-1125 (2001).
32. Oliff, H. S. & Gallardo, K. A. The effect of nicotine on developing brain catecholamine systems. Front. Biosci. 4, D883-D897 (1999).
33. Fried, P. A. & Watkinson, B. Differential effects on facets of attention in adolescents prenatally exposed to cigarettes and marihuana. Neurotoxicol. Teratol. 23, 421-430 (2001).
34. Cornblatt, B. A. & Malhotra, A. K. Impaired attention as an endophenotype for molecular genetic studies of schizophrenia. Am. J. Med. Genet. 105, 11-15 (2001).
35. Quay, H. C. in Handbook of Disruptive Behavior Disorders (eds Quay, H. C. & Hogan, A. E.) 3-21 (Plenum, New York, 1999).
36. Teicher, M. H., Ito, Y. Glod, C. A. & Barber, N. I. Objective measurement of hyperactivity and attentional problems in ADHD. J. Am. Acad. Child Adolesc. Psychiatry 35, 334-342 (1996).
37. Teicher, M. H. et al. Functional deficits in basal ganglia of children with attention-deficit/hyperactivity disorder shown with functional magnetic resonance imaging relaxometry. Nature Med. 6, 470-473 (2000).
38. Anderson, C. M., Polcari, A. M., Lowen, S. B., Renshaw, P. F. & Teicher, M. H. Effects of methylphenidate on functional magnetic resonance relaxometry of the cerebellar vermis in children with ADHD. Am. J. Psychiatry (in the press).
39. Porrino, L. J. et al. A naturalistic assessment of the motor activity of hyperactive boys. I. Comparison with normal controls. Arch. Gen. Psychiatry 40, 681-687 (1983).
40. Antrop, L. Roeyers, H., Van Oost, P. & Buysse, A. Stimulation seeking and hyperactivity in children with ADHD. J. Child Psychol. Psychiatry 41, 225-231 (2000).
41. Corkum, P., Tannock, R., Moldofsky, H., Hogg-Johnson, S. & Humphries, T. Actigraphy and parental ratings of sleep in children with attention-deficit-hyperactivity disorder (ADHD). Sleep 24, 303-312 (2001).
42. Ferguson, S. A. in Stimulant Drugs and ADHD: Basic and Clinical Neuroscience (eds Solanto, M. V., Arnsten, A. F. T. & Castellanos, F. X.) 209-220 (Oxford Univ. Press, New York, 2001).
43. Shaywitz, B. A., Yager, R. D. & Klopper, J. H. Selective brain dopamine depletion in developing rats: an experimental model of minimal brain dysfunction. Science 191, 305-308 (1976).
44. Cardinal, R. N., Pennicott, D. R., Sugathapala, C. L., Robbins, T. W. & Everitt, B. J. Impulsive choice induced in rats by lesions of the nucleus accumbens core. Science 292, 2499-2501 (2001).
45. Giros, B., Jaber, M., Jones, S. R. Wightman, R. M. & Caron, M. G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379, 606-612 (1996).
46. Viggiano, D., Grammatikopoulos, G. & Sadile, A. G. A morphometric evidence for a hyperfunctioning mesolimbic system in an animal model of ADHD. Behav. Brain Res. 130, 181-189 (2002).
47. Solanto, M. V., Arnsten, A. F. T. & Castellanos, F. X. in Stimulant Drugs and ADHD: Basic and Clinical Neuroscience (eds Solanto, M. V., Arnsten, A. F. T. & Castellanos, F. X.) 355-379 (Oxford Univ. Press, New York, 2001).
48. Todd, R. D. & Botteron, K. N. Is attention-deficit/ hyperactivity disorder an energy deficiency syndrome? Biol. Psychiatry 50, 151-158 (2001).
49. Castellanos, F. X. in Stimulant Drugs and ADHD: Basic and Clinical Neuroscience (eds Solanto, M. V., Arnsten, A. F. T. & Castellanos, F. X.) 243-258 (Oxford Univ. Press, New York, 2001).
50. Castellanos, F. X. et al. Quantitative brain magnetic resonance imaging in girls with attention-deficit/hyperactivity disorder. Arch. Gen. Psychiatry 58, 289-295 (2001).
51. Dougherty, D. D. et al. Dopamine transporter density is elevated in patients with attention deficit hyperactivity disorder. Lancet 354, 2132-2133 (1999).
52. Krause, K. H., Dresel, S. H., Krause, J., Kung, H. F. & Tatsch, K. Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography. Neurosci. Lett. 285, 107-110 (2000).
53. van Dyck, C. H. et al. Unaltered dopamine transporter availability in adult attention deficit hyperactivity disorder. Am. J. Psychiatry 159, 309-312 (2002).
54. Castellanos, F. X. Toward a pathophysiology of attention-deficit/hyperactivity disorder. Clin. Pediatr. 36, 381-393 (1997).
55. Ernst, M., Zametkin, A. J., Matochik, J. A., Jons, P. H. & Cohen, R. M. DOPA decarboxylase activity in attention deficit hyperactivity disorder adults. A [fluorine-18]fluorodopa positron emission tomographic study. J. Neurosci. 18, 5901-5907 (1998).
56. 18F-DOPA accumulation in children with ADHD. Am. J. Psychiatry 156, 1209-1215 (1999).
57. Pennington, B. F. & Ozonoff, S. Executive functions and developmental psychopathology. J. Child Psychol. Psychiatry 37, 51-87 (1996).
58. Nigg, J. T. On inhibition/disinhibition in developmental psychopathology: views from cognitive and personality psychology and a working inhibition taxonomy. Psychol. Bull. 126, 220-246 (2000).
59. Oosterlaan, J., Logan, G. D. & Sergeant, J. A. Response inhibition in AD/HD, CD, comorbid AD/HD + CD, anxious, and control children: a meta-analysis of studies with the stop task J. Child Psychol. Psychiatry 39, 411-425 (1998).
60. Solanto, M. V. et. al. The ecological validity of delay aversion and response inhibition as measures of impulsivity in AD/HD: a supplement to the NIMH multimodal treatment study of AD/HD. J. Abnorm. Child Psychol. 29, 215-228 (2001).
61. Logan, G. D., Cowan, W. B. & Davis, K. A. On the ability to inhibit simple and choice reaction time responses: a model and a method. J. Exp. Psychol. Hum. Percept. Perform. 10, 276-291 (1984).
62. Crosbie, J. & Schachar, R. Deficient inhibition as a marker for familial ADHD. Am. J. Psychiatry 158, 1884-1890 (2001).
63. Chhabildas, N., Pennington, B. F. & Willcutt, E. G. A comparison of the neuropsychological profiles of the DSM-IV subtypes of ADHD. J. Abnorm. Child Psychol. 29, 529-540 (2001).
64. Tripp, G. & Alsop, B. Sensitivity to reward delay in children with attention deficit hyperactivity disorder (ADHD). J. Child Psychol. Psychiatry 42, 691-698 (2001).
65. Schultz, W. Reward signaling by dopamine neurons. Neuroscientist 7, 293-302 (2001).
66. Johansen, E. B., Aase, H., Meyer, A. & Sagvolden, T. Attention-deficit/hyperactivity disorder (ADHD) behaviour explained by dysfunctioning reinforcement and extinction processes. Behav. Brain Res. 130, 37-45 (2002).
67. Barkley, R. A., Edwards, G., Laneri, M., Fletcher, K. & Metevia, L. Executive functioning, temporal discounting, and sense of time in adolescents with attention deficit hyperactivity disorder (ADHD) and oppositional defiant disorder (ODD). J. Abnorm. Child Psychol. 29, 541-556 (2001).
68. Madras, B. K., Miller, G. M. & Fischman, A. J. The dopamine transporter: relevance to attention deficit hyperactivity disorder (ADHD). Behav. Brain Res. 130, 57-63 (2002).
69. Knutson, B., Adams, C. M., Fong, G. W. & Hommer, D. Anticipation of increasing monetary reward selectively recruits nucleus accumbens. J. Neurosci. 21, RC159 (2001).
70. Berquin, P. C. et al. The cerebellum in attention-deficit/hyperactivity disorder a morphometric study. Neurology 50, 1087-1093 (1998).
71. Mostofsky, S. H., Reiss, A. L., Lockhart, P. & Denckla, M. B. Evaluation of cerebellar size in attention-deficit hyperactivity disorder. J. Child Neurol. 13, 434-439 (1998).
72. Melchitzky, D. S. & Lewis, D. A. Tyrosine hydroxylase-and dopamine transporter-immunoreactive axons in the primate cerebellum. Evidence for a lobular-and laminar-specific dopamine innervation. Neuropsychopharmacology 22, 466-472 (2000).
73. Snider, R. S., Maiti, A. & Snider, S. R. Cerebellar pathways to ventral midbrain and nigra. Exp. Neurol. 53, 714-728 (1976).
74. Dempesy, C. W. et al. Stimulation of the paleocerebellar cortex of the cat: increased rate of synthesis and release of catecholamines at limbic sites. Biol. Psychiatry 18, 127-132 (1983).
75. Ernst, M. et al. Intravenous dextroamphetamine and brain glucose metabolism. Neuropsychopharmacology 17, 391-401 (1997).
76. Volkow, N. D. et al. Effects of methylphenidate on regional brain glucose metabolism in humans: relationship to dopamine D2 receptors. Am. J. Psychiatry 154, 50-55 (1997).
77. Corkum, P. V. & Siegel, L. S. Is the continuous performance test a valuable research tool for use with children with attention-deficit-hyperactivity disorder? J. Child Psychol. Psychiatry 34, 1217-1239 (1993).
78. Koelega, H. S. Is the continuous performance task useful in research with ADHD children? Comments on a review. J. Child Psychol. Psychiatry 36, 1477-1485 (1995).
79. Rosvold, H. E., Mirsky, A. F., Sarason, I., Bransome, E. D. & Beck, L. H. A continuous performance test of brain damage. J. Consult. Psychol. 20, 343-350 (1956).
80. Douglas, V. I. in Handbook of Disruptive Behavior Disorders (eds Quay, H. C. & Hogan, A. E.) 105-138 (Plenum, New York, 1999).
81. Kuntsi, J. & Stevenson, J. Psychological mechanisms in hyperactivity. II. The role of genetic factors. J. Child Psychol. Psychiatry 42, 211-219 (2001).
82. Kuntsi, J., Oosterlaan, J. & Stevenson, J. Psychological mechanisms in hyperactivity. I. Response inhibition deficit, working memory impairment, delay aversion, or something else? J. Child Psychol. Psychiatry 42, 199-210 (2001).
83. Barkley, R. A., Koplowitz, S., Anderson, T. & McMurray, M. B. Sense of time in children with ADHD: effects of duration, distraction, and stimulant medication. J. Int. Neuropsychol. Soc. 3, 359-369 (1997).
84. Barkley, R. A., Murphy, K. R. & Bush, T. Time perception and reproduction in young adults with attention deficit hyperactivity disorder. Neuropsychology 15, 351-360 (2001).
85. Meck, W. H. Neuropharmacology of timing and time perception. Brain Res. Cogn. Brain Res. 3, 227-242 (1996).
86. Ivry, R. Cerebellar timing systems. Int. Rev. Neurobiol. 41, 555-573 (1997).
87. Ivry, R. B. The representation of temporal information in perception and motor control. Curr. Opin. Neurobiol. 6, 851-857 (1996).
88. Smith, A., Taylor, E., Rogers, J. W., Newman, S. & Rubia, K. Evidence for a pure time perception deficit in children with ADHD. J. Child Psychol. Psychiatry 43, 529-542 (2002).
89. Nicolson, R. I., Fawcett, A. J. & Dean, P. Developmental dyslexia: the cerebellar deficit hypothesis. Trends Neurosci. 24, 508-511 (2001).
90. Castellanos, F. X. et al. Quantitative brain magnetic resonance imaging in attention-deficit/hyperactivity disorder. Arch. Gen. Psychiatry 53, 607-616 (1996).
91. Castellanos, F. X. et al. Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA (in the press).
92. Ivry, R. Exploring the role of the cerebellum in sensory anticipation and timing: commentary on Tesche and Karhu. Hum. Brain Mapp. 9, 115-118 (2000).
93. Egan, M. F. et al. Effect of COMT Val108/158 Met genotype on frontal lobe funcfon and risk for schizophrenia. Proc. Natl Acad. Sci. USA 98, 6917-6922 (2001).
94. 2 dopamine receptors. J. Pharmacol. Exp. Ther. 290, 1493-1501 (1999).
95. Ruskin, D. N. et al. Drugs used in the treatment of attention deficit/hyperactivity disorder affect postsynaptic firing rate and oscillation without preferential autoreceptor action. Biol. Psychiatry 49, 340-350 (2001).
96. Ehlers, C. L. & Foote, S. L. Ultradian periodicities in EEG and behavior in the squirrel monkey (Saimiri sciureus). Am. J. Primatol. 7, 381-389 (1984).
97. Borger, N. & Van der Meere, J. Motor control and state regulation in children with ADHD: a cardiac response study. Biol. Psychol. 51, 247-267 (2000).
98. Miyake, A. & Shah, P. in Models of Working Memory: Mechanisms of Active Maintenance and Control (eds Miyake, A. & Shah, P.) 442-481 (Cambridge Univ. Press, Cambridge, UK, 1999).
99. Conway, A. R., Cowan, N. & Bunting, M. F. The cocktail party phenomenon revisited: the importance of working memory capacity. Psychon. Bull. Rev. 8, 331-335 (2001).
100. de Fockert, J. W. Rees, G., Frith, C. D. & Lavie, N. The role of working memory in visual selective attention. Science 291, 1803-1806 (2001).
101. Braver, T. S. et al. A parametric study of prefrontal cortex involvement in human working memory. Neuroimage 5, 49-62 (1997).
102. Carlson, S. et al. Distribution of cortical activation during visuospatial n-back tasks as revealed by functional magnetic resonance imaging. Cereb. Cortex 8, 743-752 (1998).
103. Arnsten, A. F. T. in Stimulant Drugs and ADHD: Basic and Clinical Neuroscience (eds Solanto, M. V., Arnsten, A. F. T. & Castellanos, F. X.) 185-208 (Oxford Univ. Press, New York, 2001).
104. Ellis, K. A. & Nathan, P. J. The pharmacology of human working memory. Int. J. Neuropsychopharmacol. 4, 299-313 (2001).
105. Denney, C. B. & Rapport, M. D. in Stimulant Drugs and ADHD: Basic and Clinical Neuroscience (eds Solanto, M. V. Arnsten, A. F. T. & Castellanos, F. X.) 283-302 (Oxford Univ. Press, New York, 2001).
106. Welsh, M. C. in Developmental Variations in Learning: Applications to Social, Executive Function, Language, and Reading Skills (eds Molfese, D. L. & Molfese, V. J.) 139-185 (Lawrence Erlbaum, Mahwah, New Jersey, 2002).
107. Barnett, R. et al. Abnormal executive function in attention deficit hyperactivity disorder: the effect of stimulant medication and age on spatial working memory. Psychol. Med. 31, 1107-1115 (2001).
108. Kempton, S. et al. Executive function and attention deficit hyperactivity disorder: stimulant medication and better executive function performance in children. Psychol. Med. 29, 527-538 (1999).
109. Nigg, J. T., Blaskey, L. G., Huang-Pollock, C. L. & Rappley, M. D. Neuropsychological executive functions and DSM-IV ADHD subtypes. J. Am. Acad. Child Adolesc. Psychiatry 41, 59-66 (2002).
110. Schweitzer, J. B. et al. Alterations in the functional anatomy of working memory in adult attention deficit hyperactivity disorder. Am. J. Psychiatry 157, 278-280 (2000).
111. Sawaguchi, T. The effects of dopamine and its antagonists on directional delay-period activity of prefrontal neurons in monkeys during an oculomotor delayed-response task. Neurosci. Res. 41, 115-128 (2001).
112. Mattay, V. S. et al. Effects of dextroamphetamine on cognitive performance and cortical activation. Neuroimage 12, 268-275 (2000).
113. Eisenberg, J. et al. Haplotype relative risk study of catechol-O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD): association of the high-enzyme activity val allele with ADHD impulsive-hyperactive phenotype. Am. J. Med. Genet. 88, 497-502 (1999).
114. Barr, C. L. et al. Linkage study of catechol-O-methyltransferase and attention-deficit hyperactivity disorder. Am. J. Med. Genet. 88, 710-713 (1999).
115. Hawi, Z., Millar, N., Daly, G., Fitzgerald, M. & Gill, M. No association between catechol-O-methyltransferase (COMT) gene polymorphism and attention deficit hyperactivity disorder (ADHD) in an Irish sample. Am. J. Med. Genet. 96, 282-284 (2000).
116. Tahir, E. et al. No association between low-and high-activity catecholamine-methyl-transferase (COMT) and attention deficit hyperactivity disorder (ADHD) in a sample of Turkish children. Am. J. Med. Genet 96, 285-288 (2000).
117. Castellanos, F. X. & Swanson, J. in Hyperactivity and Attention Disorders in Childhood (ed. Sandberg, S.) 335-366 (Cambridge Univ. Press, Cambridge, UK, 2002).
118. Monastra, V. J., Lubar, J. F. & Linden, M. The development of a QEEG scanning process for ADHD: reliability and validity studies. Neuropsychology 15, 136-144 (2001).
119. Clarke, A. R., Barry, R. J., McCarthy, R. & Selikowitz, M. Electroencephalogram differences in two subtypes of attention-deficit/hyperactivity disorder. Psychophysiology 38, 212-221 (2001).
120. Lazzaro, I. et al. Simultaneous EEG and EDA measures in adolescent attention deficit hyperactivity disorder. Int. J. Psychophysiol. 34, 123-134 (1999).
121. Raghavachari, S. et al. Gating of human theta oscillations by a working memory task. J. Neurosci. 21, 3175-3183 (2001).
122. Tesche, C. D. & Karhu, J. Theta oscillations index human hippocampal activation during a working memory task. Proc. Natl Acad. Sci. USA 97, 919-924 (2000).
123. Offord, D. R. et al. Integrating assessment data from multiple informants. J. Am. Acad. Child Adolesc. Psychiatry 35, 1078-1085 (1996).
124. Gould, T. D., Bastain, T. M., Israel, M. E., Hommer, D. W. & Castellanos, F. X. Altered performance on an ocular fixation task in attention-deficit/hyperactivity disorder. Biol. Psychiatry 50, 633-635 (2001).
125. Moll, G. H., Heinrich, H., Trott, G., Wirth, S. & Rothenberger, A. Deficient intracortical inhibition in drug-naive children with attention-deficit hyperactivity disorder is enhanced by methylphenidate. Neurosci. Lett. 284, 121-125 (2000).
126. Heinrich, H., Dickhaus, H., Rothenberger, A., Heinrich, V. & Moll, G. H. Single-sweep analysis of event-related potentials by wavelet networks - methodological basis and clinical application. IEEE Trans. Biomed. Eng. 46, 867-879 (1999).
127. Cowan, R. L. et al. Sex differences in response to red and blue light in human primary visual cortex: a BOLD fMRI study. Psychiatry Res. 100, 129-138 (2000).
128. Todd, R. D. et al. Familiality and heritability of subtypes of attention deficit hyperactivity disorder in a population sample of adolescent female twins. Am. J. Psychiatry 158, 1891-1898 (2001).
129. Thapar, A., Hervas, A. & McGuffin, P. Childhood hyperactivity scores are highly heritable and show sibling competition effects: twin study evidence. Behav. Genet. 25, 537-544 (1995).
130. Simonoff, E. et al. Genetic influences on childhood hyperactivity: contrast effects imply parental rating bias, not sibling interaction. Psychol. Med. 28, 825-837 (1998).
131. Conners, C. K. Clinical use of rating scales in diagnosis and treatment of attention-deficit/hyperactivity disorder. Pediatr. Clin. North Am. 46, 857-870 (1999).
132. Frick, P. J. et al. DSM-IV field trials for the disruptive behavior disorders: symptom utility estimates. J. Am. Acad. Child Adolesc. Psychiatry 33, 529-539 (1994).
133. Angold, A. & Costello, E. J. The child and adolescent psychiatric assessment (CAPA). J. Am. Acad. Child Adolesc. Psychiatry 39, 39-48 (2000).
134. Mota, V. L. & Schachar, R. J. Reformulating attention-deficit/hyperactivity disorder according to signal detection theory. J. Am. Acad. Child Adolesc. Psychiatry 39, 1144-1151 (2000).
135. Cook, E. H. Jr et al. Association of attention deficit disorder and the dopamine transporter gene. Am. J. Hum. Genet. 56, 993-998 (1995).
136. Faraone, S. V., Doyle, A. E., Mick, E. & Biederman, J. Meta-analysis of the association between the 7-repeat allele of the dopamine D4 receptor gene and attention deficit hyperactivity disorder. Am. J. Psychiatry 158, 1052-1057 (2001).
137. Scheres, A., Oosterlaan, J. & Sergeant, J. A. Response execution and inhibition in children with AD/HD and other disruptive disorders: the role of behavioural activation. J. Child Psychol. Psychiatry 42, 347-357 (2001).
138. Tannock, R. in Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder: an Evidence-Based Approach (eds Jensen, P. & Cooper, J.) (American Medical Association Press, New York, in the press).
139. Casey, B. J. et al. Implication of right frontostriatal circuitry in response inhibition and attention-deficit/hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry 36, 374-383 (1997).
140. Rubia, K. et al. Hypofrontality in attention deficit hyperactivity disorder during higher-order motor control: a study with functional MRI. Am. J. Psychiatry 156, 891-896 (1999).
141. Saunders, C. et al. Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism. Proc. Natl Acad. Sci. USA 97, 6850-6855 (2000).
142. Swanson, J. & Volkow, N. D. in Stimulant Drugs and ADHD: Basic and Clinical Neuroscience (eds Solanto, M. V., Arnsten, A. F. T. & Castellanos, F. X.) 259-282 (Oxford Univ. Press, New York, 2001).
143. Arnold, L. E. Responders and nonresponders. J. Am. Acad. Child Adolesc. Psychiatry 35, 1569-1570 (1996).
144. Vorkow, N. D. et al. Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in human brain. Arch. Gen. Psychiatry 52, 456-463 (1995).
145. Andersen, S. L., Arvanitogiannis, A., Pliakas, A. M., LeBlanc, C. & Carlezon, W. A. Jr. Altered responsiveness to cocaine in rats exposed to methylphenidate during development. Nature Neurosci. 5, 13-14 (2002).